{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:45:07Z","timestamp":1792784707943,"version":"4.5.0"},"reference-count":36,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515110185"],"award-info":[{"award-number":["2025A1515110185"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["31970870"],"award-info":[{"award-number":["31970870"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["32270993"],"award-info":[{"award-number":["32270993"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The stimulator of interferon (IFN) genes (STING) pathway has garnered considerable attention due to its significant potential in anti-cancer effect. However, cyclic dinucleotides (CDNs), which are natural agonists or their derivatives for STING, are often hindered by their inherent properties of poor transmembrane permeability and potential systemic toxicity. Herein, we employed polyethylenimine (PEI)-functionalized spiky TiO2 microparticles (SP-PEI) for the efficient delivery of CDNs into antigen-presenting cells (APCs). This delivery system leverages the electrostatic interaction between PEI and CDNs, allowing for the absorption of CDNs onto the spiky microparticle (SP) structure. Furthermore, the optimized microstructure of SP-PEI facilitates preferential phagocytosis by APCs, thereby enabling effective intracellular delivery of CDNs. Our findings demonstrated that SP-PEI significantly promoted CDNs phagocytosis by dendritic cells (DCs), leading to robust activation of the STING pathway and subsequent induction of type I interferons, which in turn fostered DC maturation. Furthermore, in MC38 tumor models, SP-PEI-CDN was observed to significantly delay the progression of both primary and distant tumors. Finally, the co-administration of SP-PEI-CDN with the chemotherapeutic agent doxorubicin (DOX) achieved excellent therapeutic efficacy against melanoma in both primary and distant tumor sites, underscoring the broad effectiveness of our delivery strategy.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.5c01695","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:25:01Z","timestamp":1788452701000},"page":"4805-4819","source":"Crossref","is-referenced-by-count":0,"title":["Functionalized Spiky Microcarriers Orchestrate STING Activation and Durable Antitumor Immunity"],"prefix":"10.1021","volume":"23","author":[{"given":"Liru","family":"Shang","sequence":"first","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510080"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Peng","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510080"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangping","family":"Huang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510080"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiguanxi","family":"Deng","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510080"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510080"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7406-8444","authenticated-orcid":true,"given":"Xi","family":"Xie","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-5937","authenticated-orcid":true,"given":"Hui-jiuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510006"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices , , ,","place":["Beijing, China, 100081"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-3264","authenticated-orcid":true,"given":"Ji","family":"Wang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510080"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1575-0010","authenticated-orcid":true,"given":"Xiafeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Sun Yat-Sen University , , ,","place":["Guangzhou, China, 510080"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"26","key":"2026100509321813400_cit1","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/nejmoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6382","key":"2026100509321813400_cit2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"2026100509321813400_cit3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-immunol-070621-030155","article-title":"Resistance Mechanisms to Anti-PD Cancer Immunotherapy","volume":"40","author":"Vesely","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"2026100509321813400_cit4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","article-title":"Tumor-infiltrating lymphocytes in the immunotherapy era","volume":"18","author":"Paijens","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"11","key":"2026100509321813400_cit5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8(+) T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"2026100509321813400_cit6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nri3921","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"2026100509321813400_cit7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.cd-19-0761","article-title":"The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discovery"},{"issue":"1","key":"2026100509321813400_cit8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS\u2012STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"2026100509321813400_cit9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"STING: a master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"7743","key":"2026100509321813400_cit10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-019-0928-6","article-title":"Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling","volume":"566","author":"Eaglesham","year":"2019","journal-title":"Nature"},{"key":"2026100509321813400_cit11","doi-asserted-by":"publisher","first-page":"15534","DOI":"10.1038\/ncomms15534","article-title":"USP13 negatively regulates antiviral responses by deubiquitinating STING","volume":"8","author":"Sun","year":"2017","journal-title":"Nat. Commun."},{"key":"2026100509321813400_cit12","doi-asserted-by":"publisher","first-page":"19049","DOI":"10.1038\/srep19049","article-title":"Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"2026100509321813400_cit13","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00262-015-1713-5","article-title":"STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice","volume":"64","author":"Wang","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"2026100509321813400_cit14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1078-0432.ccr-21-1963","article-title":"Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced\/Metastatic Solid Tumors or Lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"2026100509321813400_cit15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/2051013613501988","article-title":"Rationale, progress and development of vaccines utilizing STING-activating cyclic dinucleotide adjuvants","volume":"1","author":"Dubensky","year":"2013","journal-title":"Ther. Adv. Vaccines"},{"issue":"1","key":"2026100509321813400_cit16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","article-title":"Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion","volume":"53","author":"Wu","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"2026100509321813400_cit17","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4049\/jimmunol.1601999","article-title":"Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death","volume":"199","author":"Larkin","year":"2017","journal-title":"J. Immunol."},{"issue":"6480","key":"2026100509321813400_cit18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau0810","article-title":"Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity","volume":"367","author":"Wang","year":"2020","journal-title":"Science"},{"issue":"3","key":"2026100509321813400_cit19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41565-018-0342-5","article-title":"Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy","volume":"14","author":"Shae","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"2026100509321813400_cit20","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41565-023-01447-7","article-title":"Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles","volume":"18","author":"Dosta","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"2026100509321813400_cit21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41565-018-0274-0","article-title":"Physical activation of innate immunity by spiky particles","volume":"13","author":"Wang","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"2026100509321813400_cit22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1021\/acscentsci.8b00749","article-title":"Functionalized Spiky Particles for Intracellular Biomolecular Delivery","volume":"5","author":"Chen","year":"2019","journal-title":"ACS Cent. Sci."},{"issue":"8061","key":"2026100509321813400_cit23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41586-025-08758-w","article-title":"STING agonist-based ER-targeting molecules boost antigen cross-presentation","volume":"641","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"2026100509321813400_cit24","doi-asserted-by":"publisher","first-page":"103119","DOI":"10.1016\/j.cis.2024.103119","article-title":"PEI-based functional materials: Fabrication techniques, properties, and biomedical applications","volume":"325","author":"Fattahi","year":"2024","journal-title":"Adv. Colloid Interface Sci."},{"key":"2026100509321813400_cit25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pharmthera.2018.06.007","article-title":"Chloroquine and nanoparticle drug delivery: A promising combination","volume":"191","author":"Pelt","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"2026100509321813400_cit26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ddr.10023","article-title":"Interaction of nocodazole with tubulin isotypes","volume":"55","author":"Xu","year":"2002","journal-title":"Drug Dev. Res."},{"issue":"1","key":"2026100509321813400_cit27","doi-asserted-by":"publisher","first-page":"11371","DOI":"10.1038\/srep11371","article-title":"Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells","volume":"5","author":"Patin\u0303o","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"2026100509321813400_cit28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-024-01971-5","article-title":"Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system","volume":"9","author":"Chang","year":"2024","journal-title":"Signal Transduction Targeted Ther."},{"issue":"3","key":"2026100509321813400_cit29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3892\/or.2010.1128","article-title":"Optimization of activation requirements of immature mouse dendritic JAWSII cells for in vivo application","volume":"25","author":"Zapala","year":"2011","journal-title":"Oncol. Rep."},{"issue":"7","key":"2026100509321813400_cit30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"issue":"3","key":"2026100509321813400_cit31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.celrep.2019.09.089","article-title":"Magnitude of Therapeutic STING Activation Determines CD8(+) T Cell-Mediated Anti-tumor Immunity","volume":"29","author":"Sivick","year":"2019","journal-title":"Cell Rep."},{"issue":"10400","key":"2026100509321813400_cit32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/s0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"2026100509321813400_cit33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jconrel.2024.07.004","article-title":"Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment","volume":"373","author":"Lee","year":"2024","journal-title":"J. Contr. Release"},{"issue":"29","key":"2026100509321813400_cit34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adw0797","article-title":"Temporally programmed STING nanoadjuvant delivery unlocks synergistic chemotherapy-induced antitumor immunity","volume":"11","author":"Yang","year":"2025","journal-title":"Sci. Adv."},{"issue":"2","key":"2026100509321813400_cit35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/s1470-2045(18)30015-9","article-title":"Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial","volume":"19","author":"Amaria","year":"2018","journal-title":"Lancet Oncol."},{"key":"2026100509321813400_cit36","doi-asserted-by":"publisher","first-page":"102845","DOI":"10.1016\/j.ctrv.2024.102845","article-title":"Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives","volume":"131","author":"Parisi","year":"2024","journal-title":"Cancer Treat. Rev."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c01695","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4805\/68201764\/mp5c01695.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/23\/10\/4805\/68201764\/mp5c01695.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:49:10Z","timestamp":1791208150000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/23\/10\/4805\/5405434\/Functionalized-Spiky-Microcarriers-Orchestrate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,2]]},"published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c01695","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}